FiercePharma

January 13, 2009

"Can Obesity Treatment be Cost-effective?"

Fill in your name and email address below to read how to help bring your product to approval.

Lazard Capital Markets

November 20, 2008

"Obesity Physician Panel; payers cite challenges; bariatric physicians more optimistic"

Fill in your name and email address below to read how to help bring your product to approval.

Rodman&Renshaw

November 6, 2008

"Payor Survey: Clearing the Path to a Successful Commercial Launch of Denosumab"

Fill in your name and email address below to read how to help bring your product to approval.

ICAD

Article September 22, 2008

"Landmark Discovery for Alzheimer’s Disease in Managed Markets"

Fill in your name and email address below to read how to help bring your product to approval.

FiercePharma

Article September 8, 2008

"Generic Erosion:  How Osteoporosis Category Impacts Current and Future Market Entrants"

Fill in your name and email address below to read how to help bring your product to approval.

FiercePharma

Article July 1, 2008

"Industry Voices: Personalized Medicine Will Drive Management, Restrictions by Health Plans."

Fill in your name and email address below to read how to help bring your product to approval.

Reimbursement Intelligence Monitor:
Insights for Biocapital Investors Newsletter

Key topics include:

• Medicare Part D and Biologics
• Reimbursement: Closing the Due Diligence Circuit
• Winning P&T Launch Plan
• Off Label Use and Oncology Management Trends

Oncology and Off Label Use: Trends in Management by Health Plans

Article March 14, 2008

Article reviews the current trends in management of high cost oncology agents.

Fill in your name and email address below to read how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Medicare Part D 2008: Implications and Challenges for Biotech Products.
February 21, 2008.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Reimbursement Due Diligence For Biotech Investments. January 11, 2008.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Overview of the formulary process for Biotech and speciality products.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.